Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2009 2
2011 1
2012 1
2013 3
2014 2
2015 2
2016 1
2017 3
2018 3
2019 5
2020 2
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
Overcoming barriers by local drug delivery with liposomes.
Antimisiaris SG, Marazioti A, Kannavou M, Natsaridis E, Gkartziou F, Kogkos G, Mourtas S. Antimisiaris SG, et al. Among authors: marazioti a. Adv Drug Deliv Rev. 2021 Jul;174:53-86. doi: 10.1016/j.addr.2021.01.019. Epub 2021 Feb 2. Adv Drug Deliv Rev. 2021. PMID: 33539852 Review.
KRAS signaling in malignant pleural mesothelioma.
Marazioti A, Krontira AC, Behrend SJ, Giotopoulou GA, Ntaliarda G, Blanquart C, Bayram H, Iliopoulou M, Vreka M, Trassl L, Pepe MAA, Hackl CM, Klotz LV, Weiss SAI, Koch I, Lindner M, Hatz RA, Behr J, Wagner DE, Papadaki H, Antimisiaris SG, Jean D, Deshayes S, Grégoire M, Kayalar Ö, Mortazavi D, Dilege Ş, Tanju S, Erus S, Yavuz Ö, Bulutay P, Fırat P, Psallidas I, Spella M, Giopanou I, Lilis I, Lamort AS, Stathopoulos GT. Marazioti A, et al. EMBO Mol Med. 2022 Feb 7;14(2):e13631. doi: 10.15252/emmm.202013631. Epub 2021 Dec 13. EMBO Mol Med. 2022. PMID: 34898002 Free PMC article.
Osteopontin drives KRAS-mutant lung adenocarcinoma.
Giopanou I, Kanellakis NI, Giannou AD, Lilis I, Marazioti A, Spella M, Papaleonidopoulos V, Simoes DCM, Zazara DE, Agalioti T, Moschos C, Magkouta S, Kalomenidis I, Panoutsakopoulou V, Lamort AS, Stathopoulos GT, Psallidas I. Giopanou I, et al. Among authors: marazioti a. Carcinogenesis. 2020 Aug 12;41(8):1134-1144. doi: 10.1093/carcin/bgz190. Carcinogenesis. 2020. PMID: 31740923
RAS oncogenes direct metastasis.
Spella M, Marazioti A, Arendt KAM, Stathopoulos GT. Spella M, et al. Among authors: marazioti a. Mol Cell Oncol. 2017 Jul 5;4(5):e1345711. doi: 10.1080/23723556.2017.1345711. eCollection 2017. Mol Cell Oncol. 2017. PMID: 29057308 Free PMC article.
Mutant KRAS promotes malignant pleural effusion formation.
Agalioti T, Giannou AD, Krontira AC, Kanellakis NI, Kati D, Vreka M, Pepe M, Spella M, Lilis I, Zazara DE, Nikolouli E, Spiropoulou N, Papadakis A, Papadia K, Voulgaridis A, Harokopos V, Stamou P, Meiners S, Eickelberg O, Snyder LA, Antimisiaris SG, Kardamakis D, Psallidas I, Marazioti A, Stathopoulos GT. Agalioti T, et al. Among authors: marazioti a. Nat Commun. 2017 May 16;8:15205. doi: 10.1038/ncomms15205. Nat Commun. 2017. PMID: 28508873 Free PMC article.
Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion.
Marazioti A, Lilis I, Vreka M, Apostolopoulou H, Kalogeropoulou A, Giopanou I, Giotopoulou GA, Krontira AC, Iliopoulou M, Kanellakis NI, Agalioti T, Giannou AD, Jones-Paris C, Iwakura Y, Kardamakis D, Blackwell TS, Taraviras S, Spella M, Stathopoulos GT. Marazioti A, et al. Nat Commun. 2018 Feb 14;9(1):672. doi: 10.1038/s41467-018-03051-z. Nat Commun. 2018. PMID: 29445180 Free PMC article.
NRAS destines tumor cells to the lungs.
Giannou AD, Marazioti A, Kanellakis NI, Giopanou I, Lilis I, Zazara DE, Ntaliarda G, Kati D, Armenis V, Giotopoulou GA, Krontira AC, Lianou M, Agalioti T, Vreka M, Papageorgopoulou M, Fouzas S, Kardamakis D, Psallidas I, Spella M, Stathopoulos GT. Giannou AD, et al. Among authors: marazioti a. EMBO Mol Med. 2017 May;9(5):672-686. doi: 10.15252/emmm.201606978. EMBO Mol Med. 2017. PMID: 28341702 Free PMC article.
31 results